HomeCompareNKRKY vs MRK

NKRKY vs MRK: Dividend Comparison 2026

NKRKY yields 2.85% · MRK yields 2.76%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 MRK wins by $36.6K in total portfolio value
10 years
NKRKY
NKRKY
● Live price
2.85%
Share price
$5.27
Annual div
$0.15
5Y div CAGR
-50%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.2K
Annual income
$0.28
Full NKRKY calculator →
MRK
Merck & Co. Inc.
● Live price
2.76%
Share price
$120.31
Annual div
$3.32
5Y div CAGR
32.7%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$56.8K
Annual income
$9,798.13
Full MRK calculator →

Portfolio growth — NKRKY vs MRK

📍 MRK pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodNKRKYMRK
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, NKRKY + MRK cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
NKRKY pays
MRK pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

NKRKY
Annual income on $10K today (after 15% tax)
$241.94/yr
After 10yr DRIP, annual income (after tax)
$0.24/yr
MRK
Annual income on $10K today (after 15% tax)
$234.56/yr
After 10yr DRIP, annual income (after tax)
$8,328.41/yr
At 15% tax rate, MRK beats the other by $8,328.17/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of NKRKY + MRK for your $10,000?

NKRKY: 50%MRK: 50%
100% MRK50/50100% NKRKY
Portfolio after 10yr
$38.5K
Annual income
$4,899.21/yr
Blended yield
12.73%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on MRK right now

NKRKY
No analyst data
Altman Z
2.0
Piotroski
6/9
MRK
Analyst Ratings
25
Buy
11
Hold
1
Sell
Consensus: Buy
Price Target
$128.54
+6.8% upside vs current
Range: $100.00 — $150.00
Altman Z
4.0
Piotroski
6/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

NKRKY buys
0
MRK buys
0
No recent congressional trades found for NKRKY or MRK in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricNKRKYMRK
Forward yield2.85%2.76%
Annual dividend / share$0.15$3.32
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR-50%32.7%
Portfolio after 10y$20.2K$56.8K
Annual income after 10y$0.28$9,798.13
Total dividends collected$287.00$28.9K
Payment frequencyquarterlyquarterly
SectorStockHealthcare

Year-by-year: NKRKY vs MRK ($10,000, DRIP)

YearNKRKY PortfolioNKRKY Income/yrMRK PortfolioMRK Income/yrGap
1← crossover$10,842$142.31$11,206$366.19$364.00MRK
2$11,673$72.10$12,650$502.35$977.00MRK
3$12,527$36.28$14,407$694.19$1.9KMRK
4$13,422$18.19$16,585$967.82$3.2KMRK
5$14,370$9.11$19,342$1,363.89$5.0KMRK
6$15,381$4.56$22,913$1,947.19$7.5KMRK
7$16,460$2.28$27,662$2,823.89$11.2KMRK
8$17,613$1.14$34,159$4,173.35$16.5KMRK
9$18,847$0.57$43,337$6,308.80$24.5KMRK
10$20,166$0.28$56,776$9,798.13$36.6KMRK

NKRKY vs MRK: Complete Analysis 2026

NKRKYStock

Nokian Renkaat Oyj develops and manufactures tires in Finland, Nordics, Russia, the rest of Europe, Asia, the Americas, and internationally. It operates through Passenger Car Tyres, Heavy Tyres, and Vianor segments. The Passenger Car Tyres segment develops and produces summer and winter tires for cars and vans. The Heavy Tyres segment offers tires for forestry machinery; and special tires for agricultural machinery, tractors, and industrial machinery, as well as retreading materials and truck tires. The Vianor segment sells car and van tires, as well as truck tires under the Nokian brand, and other tire brands; and other automotive products and services. The company offers its products through its own Vianor service centers and service centers run by partners, the Nokian Tyres Authorized Dealer (NAD) partners, the N-Tyre retailers, and other tire and vehicle retailers, as well as online stores. As of December 31, 2021, it operated 1,047 Vianor service centers; 2,282 NAD stores; and 110 N-Tyre stores. Nokian Renkaat Oyj was founded in 1898 and is headquartered in Nokia, Finland.

Full NKRKY Calculator →

MRKHealthcare

Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. It serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. The company has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV. Merck & Co., Inc. was founded in 1891 and is headquartered in Kenilworth, New Jersey.

Full MRK Calculator →
📬

Get this NKRKY vs MRK comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

NKRKY vs SCHDNKRKY vs JEPINKRKY vs ONKRKY vs KONKRKY vs MAINNKRKY vs JNJNKRKY vs ABBVNKRKY vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.